Loading…
Mechanistic studies of the anticancer activity of an octahedral hexanuclear Pt(II) cage
This study provides an in-depth mechanistic investigation of the origin of antiproliferative activity for a self-assembled platinum cage. Unlike classical platinum-based anticancer agents, this construct interacts with DNA in a non-covalent, intercalative manner and promotes DNA condensation. [Displ...
Saved in:
Published in: | Inorganica Chimica Acta 2016-10, Vol.452, p.125-129 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | This study provides an in-depth mechanistic investigation of the origin of antiproliferative activity for a self-assembled platinum cage. Unlike classical platinum-based anticancer agents, this construct interacts with DNA in a non-covalent, intercalative manner and promotes DNA condensation. [Display omitted]
•A hexanuclear platinum cage has anti-proliferative effects against human cancer cells.•Unlike classical Pt anticancer agents, this cage interacts with DNA non-covalently.•The cage intercalates into DNA and promotes DNA condensation.•In cancer cells, the cage induces DNA damage and triggers apoptosis and senescence.
The cellular response evoked by a hexanuclear platinum complex, Pt6L4 (1), is reported. Compound 1, a 3-nm octahedral cage formed by self-assembly of six Pt(II) centers and four 2,4,6-tris(4-pyridyl)-1,3,5-triazine ligands (L), exhibits promising in vitro potency against a panel of human cancer cell lines. Unlike classical platinum-based anticancer agents, 1 interacts with DNA in a non-covalent, intercalative manner and promotes DNA condensation. In cancer cells, 1 induces DNA damage, upregulates p53, its phosphorylated form phospho-p53 and its downstream effector, p21, as well as both apoptosis and senescence. |
---|---|
ISSN: | 0020-1693 1873-3255 |
DOI: | 10.1016/j.ica.2016.03.021 |